The Environmental Determinants of Diabetes in the Young (TEDDY) Study

$5,562,000UC4FY2013DKNIH

Hospital District Of Southwest Finland, Turku

Investigators

Linked publications, trials & patents

Paper 39280042 Paper 38883796 Paper 38819466 Paper 38172348 Paper 37993433 Paper 37972632 Paper 37614409 Paper 37579501 Paper 37530831 Paper 37390828 Paper 37231274 Paper 37143363 Paper 37141102 Paper 36867433 Paper 36730234 Paper 36219178 Paper 36150054 Paper 36150053 Paper 36082496 Paper 35702057 Paper 35394004 Paper 35296692 Paper 35043162 Paper 34811390 Paper 34291312 Paper 33790023 Paper 33783586 Paper 33704891 Paper 33404683 Paper 33179853 Paper 33035311 Paper 32770166 Paper 32029481 Paper 31896601 Paper 31792456 Paper 31744911 Paper 31728565 Paper 31616039 Paper 31533753 Paper 31492764 Paper 31408136 Paper 31382440 Paper 31322810 Paper 31320812 Paper 30967432 Paper 30768831 Paper 30655385 Paper 30628751 Paper 30411443 Paper 30356187 Paper 30356183 Paper 30353256 Paper 30305370 Paper 30287597 Paper 30226003 Paper 30104249 Paper 29693777 Paper 29666158 Paper 29614081 Paper 29577538 Paper 29343517 Paper 29310926 Paper 29151672 Paper 29075164 Paper 29061729 Paper 29052687 Paper 29018046 Paper 28990147 Paper 28941965 Paper 28903990 Paper 28901336 Paper 28856522 Paper 28770319 Paper 28753178 Paper 28663383 Paper 28650578 Paper 28646072 Paper 28555778 Paper 28511706 Paper 28462922 Paper 28249640 Paper 28219962 Paper 28127835 Paper 28096222 Paper 27840181 Paper 27561809 Paper 27311490 Paper 27306948 Paper 27241873 Paper 27015091 Paper 26993064 Paper 26682228 Paper 26552054 Paper 26453955 Paper 26447157 Paper 26412232 Paper 26156735 Paper 26088478 Paper 26010309 Paper 25884839

Abstract

DESCRIPTION (provided by applicant): The Environmental Determinants of Diabetes in the Young (TEDDY) study was initiated in 2003 by six clinical centers in the United States and Europe, including ours, to identify infectious agents, dietary factors, or other environmental exposures that may trigger or protect against the development of islet autoimmunity and type 1 diabetes (T1D). Additional long-term scientific goals include assessment of potential gene-environment interactions affecting development of islet autoimmunity or T1D, gaining insight on mechanisms, and sharing collected specimens with broader scientific community for studies of T1D pathogenesis and prevention. A total of 424,788 newborns have been screened by HLA-DR, DQ genotyping to identify children at increased risk for T1D and 8677 are followed four times a year until 4 years of age and twice a year thereafter until age 15. Our Clinical Center has enrolled 1834 TEDDY participants; of those 114 have developed persistent confirmed islet autoantibodies and 36 have been diagnosed with T1D, as of 6/30/2012.

View original record on NIH RePORTER →